secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sensei Biotherapeutics, Inc. (SNSE)
CIK:        0001829802
Form:       8-K
Filed at:   2024-09-20T23:59:59+00:00
Accession:  0001193125-24-222937
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Sensei Biotherapeutics appoints Josiah Craver as principal financial officer
----------------------------------------------------------------------------

- Craver appointed principal financial and accounting officer effective Sept 17, 2024; previously SVP Finance since July 2024.
- Base salary $360,000, annual bonus target 35%, and stock option for 80,000 shares vesting over 4 years.
- Severance: six months salary if terminated without cause/good reason; 12 months salary plus bonus and equity acceleration upon change in control.
- David Gaiero ceased serving as interim principal financial and accounting officer immediately.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1829802/000119312524222937/0001193125-24-222937-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1829802/000119312524222937/d881257d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-222937

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer